Navigation Links
Indian Scientists Develop Dipstick Test for Dengue

Indian researchers have developed simple, safe and cost-effective dipstick for the early detection of dengue fever. The researchers say its low cost, sensitivity and ease of// use make it better than current tests for dengue.

Nagesh Tripathi and colleagues at the India-based Defence Research and Development Establishment developed a way to efficiently produce a protein that the dengue virus uses.

The protein was incorporated into a dipstick that shows a brown dot if a patient's blood sample contains antibodies to the virus — indicating an infection.

The team is yet to work out how much the dipstick will cost commercially, and say that further testing of how the dipstick works if a patient has another viral infection — such as typhoid or malaria — is necessary.

Dengue is a mosquito-borne viral disease affecting several tropical and subtropical regions of the world. It causes an estimated 100 million infections every year, with no effective vaccine against it.

While the disease itself is rarely fatal, a complication known as dengue haemorrhagic fever kills 20 per cent of victims if they do not receive treatment.

Dengue has recently undergone a dramatic expansion in several parts of Southeast Asia (see A killer arises: the global resurgence of dengue), making early diagnosis extremely important for controlling outbreaks.

The research was published online last week (27 January) in Biotechnology Progress.

Source-Bio-Bio Technology
SI
'"/>




Page: 1

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Indian Scientists Develop Dipstick Test for Dengue

(Date:7/2/2015)... ... 02, 2015 , ... Patton State Hospital (PSH) is a ... to using Winscribe’s dictation and clinical documentation solutions, Patton State Hospital was utilizing ... dictation and transcription processes. , Over the years, PSH’s dictation service ...
(Date:7/1/2015)... ... July 01, 2015 , ... A June 19th article by the Associated Press ... cut down on the cost of medical care, specifically for seniors. Medicare recently completed the ... has already saved $25 million. Medicare’s chief medical officer, Dr. Patrick Conway said that “If ...
(Date:7/1/2015)... ... , ... Sir Fazle Hasan Abed, BRAC’s founder and chairperson, was announced as ... recognised for his outstanding contribution to enhancing the world's production and distribution of food ... Food Prize Foundation, announced this year’s winner at a ceremony at the State Department ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... they will welcome four new members to their industry leading Scientific Advisory Board. ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... new extraction plant for Linablue®, Spirulina-derived natural blue food coloring. Construction of the ... DIC Group’s U.S. Spirulina* production base, began in May 2014. After commissioning, commercial ...
Breaking Medicine News(10 mins):Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 3Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 4Health News:Article Announcing Medicare’s Cost Cutting Suggestions Shines Brightly on House Call Medicine, Comments Dr. Michael Farzam 2Health News:Article Announcing Medicare’s Cost Cutting Suggestions Shines Brightly on House Call Medicine, Comments Dr. Michael Farzam 3Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3
... the seventh leading cause of cancer death worldwide, the ... group and gender. Esophageal cancer is thought to be ... with the host genome. Researchers have long been seeking ... conducted on gene-environment interaction and gene polymorphisms for esophageal ...
... intellectual property laws devalue the "repurposing" of existing ... life-saving treatments, a Portland researcher contends. , S. ... behavioral neuroscience in the Oregon Health & Science ... Affairs Medical Center, writes in a letter appearing ...
... Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ), today ... Pharmaceuticals GmbH (Merz) for sales,by Merz and its ... severe Alzheimer,s disease for the quarter ended June ... royalty payments compared to,the same quarter last year, ...
... Oct. 31 MAP,Pharmaceuticals, Inc. (Nasdaq: ... the initiation of a Phase 2a clinical ... asthma and chronic obstructive,pulmonary disease (COPD). ... and a long-acting,beta2-agonist delivered to the respiratory ...
... and Offshore Healthcare Expertise and ... Service Delivery Capabilities EL SEGUNDO, Calif. ... CSC ) and,First Consulting Group, Inc. (Nasdaq: FCGI ) today ... through which CSC will acquire,First Consulting Group (FCG) in an all-cash ...
... EDMONTON, Oct. 31 /PRNewswire-FirstCall/ - BioMS Medical Corp ... multiple sclerosis (MS), today,announced that Mr. Kevin Giese, ... Rodman and Renshaw 9th Annual Healthcare Conference in ... 3:20 pm (Local Time), WHERE: New York ...
Cached Medicine News:Health News:ADH2 and ALDH2 are associated with esophageal cancer 2Health News:Old drugs need 'repurposing' for new uses, physician says 2Health News:MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma 2Health News:MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma 3Health News:MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma 4Health News:CSC Agrees to Acquire First Consulting Group 2Health News:CSC Agrees to Acquire First Consulting Group 3Health News:CSC Agrees to Acquire First Consulting Group 4Health News:CSC Agrees to Acquire First Consulting Group 5Health News:BioMS Medical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2
(Date:7/1/2015)... 1, 2015 The Coalition of State ... and regional professional rheumatology societies, today released the ... explored perceptions of biosimilars and the potential impact ... Biosimilars are medicines that are highly similar, ... notably different from generic medications in that it ...
(Date:7/1/2015)... N.J. , July 1, 2015 ContraVir ... focused on the development and commercialization of targeted antiviral ... Cantor Fitzgerald Inaugural Healthcare Conference taking place in ... 2015 at Le Parker Meridien Hotel. ... an overview of the Company,s business during his live ...
(Date:7/1/2015)... , July 1, 2015 Eli Lilly and Company ... the second quarter of 2015 on Thursday, July 23, 2015. ... with the investment community and media to further detail the ... at 9 a.m. EDT. Investors, media and the general public ... a link that will be posted on Lilly,s website at ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2
... AUSTIN, Texas, June 27, 2011 Luminex Corporation (NASDAQ: ... its acquisition of privately-held EraGen Biosciences, Inc., an innovator ... genetic applications, for $34 million in cash. ... EraGen acquisition will add between $5 million and $7 ...
... ChemoCentryx, Inc. today announced that the Company,s novel ... in experimental models.  These data implicate CCR2-driven processes ... associated complications such as diabetic nephropathy.  Results were ... Improves Renal Function and Hyperglycemia in Preclinical Models ...
Cached Medicine Technology:Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc. 2Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc. 3ChemoCentryx Reports Novel CCR2 Antagonist Significantly Improves Kidney Function and Hyperglycemia in Models of Type 2 Diabetes 2ChemoCentryx Reports Novel CCR2 Antagonist Significantly Improves Kidney Function and Hyperglycemia in Models of Type 2 Diabetes 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: